Plant-Derived Cannabis Formula Granted ‘Breakthrough’ Designation by FDA for Pain Treatment
The FDA's decision follows the results of a Phase 3 clinical trial concluding that patients who consumed the cannabis extract experienced greater mean pain reduction than did those who took opioids.The post Plant-Derived Cannabis Formula Granted ‘Breakthrough’ Designation by FDA for Pain Treatment appeared first on NORML.
Comments
Post a Comment